Skip to content
Medical Health Aged Care, Regional Country Services

Stroke patients will benefit from Australian Stroke Clinical Registry expansion

The Florey 3 mins read

More hospitals are about to benefit from expert stroke care monitoring 

The Australian Stroke Clinical Registry (AuSCR) at The Florey will expand its work to improve stroke care across the country, thanks to a new 3-year $1.5 million funding package under the Australian Government’s  National Clinical Quality Registry Program.  

Most state governments support the AuSCR program, but this added support will create a new sustainable partnership arrangement between all jurisdictions and the Commonwealth for stroke – a high priority national condition. 

The AuSCR data custodian, Professor Dominique Cadilhac, said the new agreement recognised the impact the stroke registry was already having on care and meant it could expand beyond the 65 hospitals it already monitors. 

“With the Commonwealth’s support, we will be able to achieve greater coverage across the country in hospitals admitting patients with stroke. Our work will extend to more locations including smaller hospitals to provide a comprehensive overview of stroke care in Australia, never previously achieved.” 

Professor Cadilhac said stroke is a major cause of disease burden and cost throughout Australia.  

“Every 19 minutes, somebody experiences their first stroke, with those in regional areas 17 per cent more likely to suffer a stroke than those in metropolitan areas. We know that smaller regional hospitals especially will benefit from our monitoring of their acute stroke care, and we look forward to working closely with them.” 

The new funding enables the AuSCR to: 

  • Expand the number of interactive data dashboards to support improvements in care 

  • Make information and up-to-date data more easily accessible to the public and researchers  

  • Share knowledge and expertise with more hospitals 

  • Report outcomes by a range of factors such as sex, ethnicity and type of stroke; and more. 

“Whether a person recovers well from stroke or has a lengthy rehabilitation can depend on the hospital where they're treated. We are working to change that, by improving gathering and sharing of information related to stroke care,” she said. 

The Australian Safety and Quality Commission in healthcare has identified stroke as one of Australia’s high-priority clinical domains. All hospitals already working with AuSCR support the National Stroke Targets which were established in 2023 with registry consortium partners and peak advocacy and clinical bodies, the Stroke Foundation and Australia and New Zealand Stroke Organisation.  

Professor Cadilhac said for Australia to align with international best practice it was essential that all hospitals have access to AuSCR’s data infrastructure as it monitored their progress against National Stroke Targets. 

“We look forward to working with our existing and new partners to improve the quality of stroke care in Australia and reach the National Stroke Targets by 2030. We’re shining a light on areas that hospitals can target for improvement, as well as highlighting areas where states are leading the way and can help others,” Professor Cadilhac said.  

The Florey’s successful submission for extra funding was on behalf of the stroke registry consortium: Stroke Foundation, Australian and New Zealand Stroke Organisation and Monash University.  

Read more about AuSCR’s work and stroke research at The Florey 

About The Florey

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementia, epilepsy, mental health and developing ways to promote brain health and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere. 

Find out more about us on our website: www.florey.edu.au  

 

 


Contact details:

Kathryn Powley, Media and Communications Manager 

kathryn.powley@florey.edu.au | 0456 666 271 

Media

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.